MEDICATION MANAGEMENT

The Collection and Disposal of Waste Medications 6/19/2008

At some point, certain medications become unused and unwanted, whether due to expiration, noncompliance, change in therapy, or other reasons.

What's News 6/19/2008

Alexandria, VA -- A survey conducted by the American Society of Health-System Pharmacists (ASHP) uncovered that the number of health system pharmacists playing a significant role in consulting with physicians on a wide range of drug protocols increased by 2% over the past six years.

My Campaign Platform 4/18/2008

As the Presidential campaigns heat up, there has been much talk about fixing the U.

Cardinal Health Helps Hospitals Efficiently Order, Store, and Dispense Drugs 2/20/2008

Cardinal Health is partnering with hospitals nationwide to help them simplify the way that they purchase and dispense medications.

InforMedix Launches Med-eMonitor 1/28/2008

The Med-eMonitor System, a new interactive smart pillbox, was developed by InforMedix to address the problem of noncompliance among patients with chronic conditions and the elderly.

The Dawn of a New Age 1/23/2008

According to the U.S. Census Bureau, the average life expectancy for Americans is 78 years.

Review of Select NMEs 10/18/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

Seniors and Drug Development 10/18/2007

Astonishingly, it is frequently observed that the efficacy and safety of new pharmaceuticals are evaluated in patient populations with significantly different characteristics from some of the patients for whom the treatments will be prescribed in clinical practice.

New Drug Review 10/18/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

Pharmacy Technicians Are Valued Resources 5/18/2007

Let's face it: There isn't a pharmacist in practice that wants to make an error.

Drug Interactions in Dermatology 4/17/2007

M.

Review of Select NMEs 3/21/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

Advertisement